Naja Nyffenegger

1PUBLICATIONS
3CO-AUTHORS
Haematology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

|Jun 17, 2022
The oral ferroportin inhibitor vamifeport improves hemodynamics in a mouse model of sickle cell disease.

Naja Nyffenegger, Rahima Zennadi, Natarajaswamy Kalleda

Pageof 1